InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Adaptive Biotechnologies Corp

ADPT Clue Score46
United States Fiscal year ends December CIK 0001478320 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Scheduled selling only

Individual transactions

36
Insider
Date
Role
Action
Shares
Price
Amount
Julie Rubinstein
3 Nov 2026
President and COO
Sold after exercise
11,881
$25.98
$308.67K
Julie Rubinstein
2 Nov 2026
President and COO
Sold after exercise
2,585
$26.34
$68.09K
Julie Rubinstein
2 Nov 2026
President and COO
Sold after exercise
9,296
$25.23
$234.54K
Julie Rubinstein
30 Oct 2026
President and COO
Sold after exercise
2,395
$27.45
$65.74K
Julie Rubinstein
30 Oct 2026
President and COO
Sold after exercise
9,486
$26.55
$251.85K
Julie Rubinstein
29 Oct 2026
President and COO
Sold after exercise
11,881
$28.27
$335.88K
Julie Rubinstein
28 Oct 2026
President and COO
Sold after exercise
200
$28.90
$5.78K
Julie Rubinstein
28 Oct 2026
President and COO
Sold after exercise
11,681
$28.44
$332.21K
Julie Rubinstein
27 Oct 2026
President and COO
Sold after exercise
8,881
$27.53
$244.49K
Julie Rubinstein
27 Oct 2026
President and COO
Sold after exercise
3,000
$26.58
$79.74K
Julie Rubinstein
26 Oct 2026
President and COO
Sold after exercise
3,378
$26.30
$88.84K
Julie Rubinstein
26 Oct 2026
President and COO
Sold after exercise
8,503
$25.94
$220.57K
Julie Rubinstein
23 Oct 2026
President and COO
Sold after exercise
7,381
$25.28
$186.59K
Julie Rubinstein
23 Oct 2026
President and COO
Sold after exercise
4,500
$24.50
$110.25K
Julie Rubinstein
22 Oct 2026
President and COO
Sold after exercise
1,700
$25.29
$42.99K
Julie Rubinstein
22 Oct 2026
President and COO
Sold after exercise
10,181
$24.38
$248.21K
Julie Rubinstein
21 Oct 2026
President and COO
Sold after exercise
5,882
$25.57
$150.40K
Julie Rubinstein
21 Oct 2026
President and COO
Sold after exercise
5,999
$25.25
$151.47K
Julie Rubinstein
20 Oct 2026
President and COO
Sold after exercise
100
$24.85
$2.49K
Julie Rubinstein
20 Oct 2026
President and COO
Sold after exercise
11,781
$24.53
$288.99K
Julie Rubinstein
19 Oct 2026
President and COO
Sold after exercise
11,881
$24.05
$285.74K
Julie Rubinstein
16 Oct 2026
President and COO
Sold after exercise
300
$25.45
$7.64K
Julie Rubinstein
16 Oct 2026
President and COO
Sold after exercise
11,581
$24.21
$280.38K
Julie Rubinstein
15 Oct 2026
President and COO
Sold after exercise
11,881
$25.61
$304.27K
Julie Rubinstein
14 Oct 2026
President and COO
Sold after exercise
5,100
$25.82
$131.68K
Julie Rubinstein
14 Oct 2026
President and COO
Sold after exercise
6,781
$25.57
$173.39K
Julie Rubinstein
13 Oct 2026
President and COO
Sold after exercise
11,881
$25.50
$302.97K
Julie Rubinstein
12 Oct 2026
President and COO
Sold after exercise
2,700
$26.07
$70.39K
Julie Rubinstein
12 Oct 2026
President and COO
Sold after exercise
9,181
$25.35
$232.74K
Julie Rubinstein
9 Oct 2026
President and COO
Sold after exercise
11,881
$26.41
$313.78K
Julie Rubinstein
8 Oct 2026
President and COO
Sold after exercise
11,881
$25.66
$304.87K
Julie Rubinstein
7 Oct 2026
President and COO
Sold after exercise
11,881
$26.40
$313.66K
Julie Rubinstein
6 Oct 2026
President and COO
Sold after exercise
499
$30.53
$15.23K
Julie Rubinstein
6 Oct 2026
President and COO
Sold after exercise
901
$29.71
$26.77K
Julie Rubinstein
6 Oct 2026
President and COO
Sold after exercise
1,100
$28.21
$31.03K
Julie Rubinstein
6 Oct 2026
President and COO
Sold after exercise
9,381
$27.36
$256.66K
Show all 37 transactions →

What was left out

Form 4 filings counted 8
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 36
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 249,501
History held since 2 Jul 2019